CF
AMPH icon

Corebridge Financial’s Amphastar Pharmaceuticals AMPH Stock Holding History

Corebridge Financial’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-19,756
Closed -$573K – 154
2025
Q1 		$573K Sell
19,756
-693
-3% -$22.1K ﹤0.01% 1513
2024
Q4 		$759K Sell
20,449
-1,613
-7% -$73.8K ﹤0.01% 1463
2024
Q3 		$1.07M Sell
22,062
-241
-1% -$10.6K 0.01% 1327
2024
Q2 		$892K Buy
+22,303
New +$924K ﹤0.01% 1388

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Corebridge Financial's AMPH Position: Q2 2025 in Review

Corebridge Financial sold out of Amphastar Pharmaceuticals (AMPH) in Q2 2025, closing a stake of 19,756 shares — an estimated $573K sold.

Corebridge Financial first reported a position in AMPH in Q2 2024 and held it in 4 quarters. The position peaked at $1.07M in Q3 2024. 245 funds tracked by Wall St. Rank hold AMPH as of Q2 2025.

  • Corebridge Financial reported no remaining Amphastar Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 19,756 Amphastar Pharmaceuticals shares in Q2 2025, an estimated $573K.
  • Corebridge Financial first reported a position in Amphastar Pharmaceuticals in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's Amphastar Pharmaceuticals position peaked at $1.07M in Q3 2024.
  • 245 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.